Cite
MLA Citation
Kerstin Kapp et al.. “EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy.” Journal for immunotherapy of cancer, vol. 7, no. 1, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100135162723.0x000004